Wang H, Liu K, Geng M, Gao P, Wu X, Hai Y, et al
Genetic Predispositions and Peptide Pathway Response Research suggests genetic variants in GLP-1 receptor (GLP1R), GIPR (GIP receptor), and metabolic genes like FTO and MC4R may influence how individuals respond to GLP-1 and dual-action peptides
524 Furthermore, copper-based metalorganic framework nanozymes mimic superoxide dismutase and catalase activities to scavenge ROS and regulate mitochondrial autophagy, thus offering a novel therapeutic avenue for AP
That translated to an estimated 8.7 million obese adults in Canada in 2022
From our data, we cannot establish whether the prolonged GLP-1R agonist treatment affects quiescent PSCs and induces them to proliferate and stay activated